UPDATE: Deutsche Bank Raises PT to $85 on Mead Johnson Nutrition

Deutsche Bank increases its price target $6 to $85 on Buy-rated Mead Johnson Nutrition

on emerging market opportunities and US market share gains. Deutsche Bank says, "Although Mead's stock has performed well with valuation reaching new heights, we nevertheless retain our BUY opinion. Particularly when focused LT, we see opportunity as emerging markets across Asia and Latin America grow rapidly, Mead continues to gain share and the U.S. market eventually rebounds." MJN closed at $79.76 a share yesterday.